Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $73,565 | 39 | 97.5% |
| Travel and Lodging | $1,166 | 7 | 1.5% |
| Food and Beverage | $595.82 | 13 | 0.8% |
| Education | $87.00 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Research & Development, LLC | $45,000 | 26 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $7,750 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $7,672 | 16 | $0 (2018) |
| Alkermes, Inc. | $6,615 | 5 | $0 (2021) |
| Sage Therapeutics, Inc. | $5,947 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $2,342 | 4 | $0 (2017) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $87.00 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,700 | 7 | Janssen Research & Development, LLC ($11,700) |
| 2023 | $10,322 | 5 | Janssen Research & Development, LLC ($7,500) |
| 2022 | $10,000 | 7 | Janssen Research & Development, LLC ($7,500) |
| 2021 | $3,155 | 3 | Sage Therapeutics, Inc. ($2,375) |
| 2020 | $3,500 | 3 | Janssen Research & Development, LLC ($3,500) |
| 2019 | $1,950 | 2 | Janssen Research & Development, LLC ($1,950) |
| 2018 | $17,994 | 25 | Otsuka America Pharmaceutical, Inc. ($7,672) |
| 2017 | $10,792 | 9 | Janssen Research & Development, LLC ($8,450) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 09/12/2024 | Neurocrine Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 07/12/2024 | Neurocrine Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 06/18/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 06/10/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 05/31/2024 | Neurocrine Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 05/09/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 12/25/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 11/16/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 10/02/2023 | Neurocrine Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 09/13/2023 | Sage Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,072.00 | General |
| 06/01/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 12/23/2022 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 07/20/2022 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 07/11/2022 | Sage Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 07/07/2022 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 07/07/2022 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 06/06/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 03/04/2022 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 04/07/2021 | Alkermes, Inc. | — | Consulting Fee | Cash or cash equivalent | $390.00 | General |
| 02/25/2021 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Consulting Fee | Cash or cash equivalent | $2,375.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 02/03/2021 | Alkermes, Inc. | — | Consulting Fee | Cash or cash equivalent | $390.00 | General |
| 12/16/2020 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 10/02/2020 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 06/09/2020 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
About Dr. Marlene Freeman, MD
Dr. Marlene Freeman, MD is a Psychiatry healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477565695.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marlene Freeman, MD has received a total of $75,413 in payments from pharmaceutical and medical device companies, with $17,700 received in 2024. These payments were reported across 61 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($73,565).
Practice Information
- Specialty Psychiatry
- Location Tucson, AZ
- Active Since 08/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1477565695
Products in Payments
- ZULRESSO (Drug) $2,875
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Tucson
Francisco Moreno, Md, MD
Psychiatry — Payments: $44,872
Jennifer Treusch, M.d, M.D
Psychiatry — Payments: $43,564
Samantha Frembgen, D.o, D.O
Psychiatry — Payments: $11,075
Dr. Shahzad Ali, Md, MD
Psychiatry — Payments: $9,985
Dr. Richard Barnes, M.d, M.D
Psychiatry — Payments: $6,630
Dr. Stephen Streitfeld, M.d, M.D
Psychiatry — Payments: $6,119